Spots Global Cancer Trial Database for metastatic malignant neoplasm
Every month we try and update this database with for metastatic malignant neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers | NCT01624766 | Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali... | Anakinra Denosumab Everolimus | 18 Years - | M.D. Anderson Cancer Center | |
| Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer | NCT01582191 | Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali... | Everolimus Laboratory Biom... Pharmacological... Vandetanib | - | M.D. Anderson Cancer Center | |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | NCT01366144 | Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc... | Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations | NCT01531361 | Advanced Malign... BRAF Gene Mutat... Metastatic Mali... Recurrent Malig... Refractory Mali... | Crizotinib Laboratory Biom... Pharmacological... Sorafenib Tosyl... Vemurafenib | 18 Years - | M.D. Anderson Cancer Center | |
| Financial Distress in Advanced Cancer Patients | NCT04053517 | Advanced Malign... Locally Advance... Metastatic Mali... Recurrent Malig... Refractory Mali... | Medical Chart R... Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery | NCT02583269 | Advanced Malign... Metastatic Mali... Unresectable Ma... | Laboratory Biom... Muscadine Grape... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences | |
| Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes | NCT02286687 | Advanced Malign... ATM Gene Mutati... BRCA1 Gene Muta... BRCA2 Gene Muta... Metastatic Mali... PALB2 Gene Muta... Recurrent Malig... Refractory Mali... | Laboratory Biom... Pharmacological... Talazoparib | 18 Years - | M.D. Anderson Cancer Center | |
| Ride to Care - Quality of Life With Transportation for RT | NCT03849742 | Locally Advance... Metastatic Mali... | Quality-of-Life... Questionnaire A... Supportive Care | 18 Years - | University of California, San Francisco | |
| Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits | NCT03856060 | Advanced Malign... Locally Advance... Malignant Neopl... Metastatic Mali... Recurrent Malig... | Questionnaire A... Video | 18 Years - | M.D. Anderson Cancer Center | |
| Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center | NCT03671226 | Advanced Malign... Caregiver Locally Advance... Metastatic Mali... | Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care | NCT03743649 | Delirium Locally Advance... Metastatic Mali... Recurrent Malig... | Haloperidol Lorazepam Placebo Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors | NCT03108131 | Skin Squamous C... Appendix Adenoc... Rare Lesion Locally Advance... Locally Advance... Metastatic Mali... Metastatic Skin... Metastatic Smal... Rare Neoplastic... Refractory Mali... Stage IV Small ... Unresectable Ma... | Atezolizumab Cobimetinib | 18 Years - | M.D. Anderson Cancer Center | |
| Ride to Care - Quality of Life With Transportation for RT | NCT03849742 | Locally Advance... Metastatic Mali... | Quality-of-Life... Questionnaire A... Supportive Care | 18 Years - | University of California, San Francisco | |
| Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes | NCT02774291 | HLA-A2 Positive... Metastatic Mali... Metastatic Mali... | Aldesleukin Anti-thyroglobu... Cyclophosphamid... Filgrastim Fludarabine Pho... Laboratory Biom... | 18 Years - 66 Years | Albert Einstein College of Medicine | |
| 18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery | NCT05174026 | Metastatic Mali... Metastatic Mali... | Fludeoxyglucose... Magnetic Resona... Positron Emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of NPX887 for Participants With Solid Tumors Known to Express HHLA2/B7-H7 | NCT06240728 | Metastatic Mali... | NPX887 | 18 Years - | NextPoint Therapeutics, Inc. | |
| Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II) | NCT02152254 | Metastatic Mali... Recurrent Malig... | Targeted Therap... Standard-of-Car... | 18 Years - | M.D. Anderson Cancer Center | |
| Methylphenidate and Physical Activity to Reduce Cancer Related Fatigue Due to Anti PD1 Immunotherapy | NCT03525873 | Advanced Malign... Metastatic Mali... Recurrent Malig... | Laboratory Biom... Methylphenidate Physical Activi... Placebo Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes | NCT02286687 | Advanced Malign... ATM Gene Mutati... BRCA1 Gene Muta... BRCA2 Gene Muta... Metastatic Mali... PALB2 Gene Muta... Recurrent Malig... Refractory Mali... | Laboratory Biom... Pharmacological... Talazoparib | 18 Years - | M.D. Anderson Cancer Center | |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery | NCT02583269 | Advanced Malign... Metastatic Mali... Unresectable Ma... | Laboratory Biom... Muscadine Grape... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences | |
| Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center | NCT03671226 | Advanced Malign... Caregiver Locally Advance... Metastatic Mali... | Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism | NCT02585713 | Cerebral Vein T... Deep Vein Throm... Gonadal Thrombo... Hepatic Thrombo... Malignant Neopl... Mesenteric Thro... Metastatic Mali... Portal Vein Thr... Pulmonary Embol... Renal Vein Thro... Splenic Thrombo... Venous Thromboe... | Apixaban Dalteparin Questionnaire A... | 18 Years - | Academic and Community Cancer Research United | |
| Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer | NCT04068649 | Metastatic Mali... | Palliative Radi... Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | Roswell Park Cancer Institute | |
| Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer | NCT01582191 | Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali... | Everolimus Laboratory Biom... Pharmacological... Vandetanib | - | M.D. Anderson Cancer Center | |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | NCT01366144 | Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc... | Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer | NCT04068649 | Metastatic Mali... | Palliative Radi... Quality-of-Life... Questionnaire A... Stereotactic Bo... | 18 Years - | Roswell Park Cancer Institute | |
| Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases | NCT01592968 | Metastatic Mali... Metastatic Mali... | Cognitive Asses... Quality-of-Life... Stereotactic Ra... Whole-Brain Rad... | 18 Years - | M.D. Anderson Cancer Center | |
| Gene Electrotransfer to Muscle With Plasmid AMEP in Patients With Disseminated Cancer | NCT01664273 | Metastatic Mali... | Plasmid AMEP | 18 Years - | Copenhagen University Hospital at Herlev | |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery | NCT02583269 | Advanced Malign... Metastatic Mali... Unresectable Ma... | Laboratory Biom... Muscadine Grape... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences | |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism | NCT02585713 | Cerebral Vein T... Deep Vein Throm... Gonadal Thrombo... Hepatic Thrombo... Malignant Neopl... Mesenteric Thro... Metastatic Mali... Portal Vein Thr... Pulmonary Embol... Renal Vein Thro... Splenic Thrombo... Venous Thromboe... | Apixaban Dalteparin Questionnaire A... | 18 Years - | Academic and Community Cancer Research United | |
| Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer | NCT02491632 | Advanced Malign... Fatigue Metastatic Mali... Recurrent Malig... Refractory Mali... | Dexamethasone Exercise Interv... Laboratory Biom... Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings | NCT04186884 | Advanced Malign... Locally Advance... Metastatic Mali... Recurrent Malig... | Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II) | NCT02152254 | Metastatic Mali... Recurrent Malig... | Targeted Therap... Standard-of-Car... | 18 Years - | M.D. Anderson Cancer Center | |
| Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care | NCT03743649 | Delirium Locally Advance... Metastatic Mali... Recurrent Malig... | Haloperidol Lorazepam Placebo Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
